Similar Papers

Paper Title
Journal
Date
Author
Abstract PD2-09: Association of quantitative MRI features with tumor infiltrating lymphocytes and treatment response prediction in HER2 positive subtype of breast cancer
Gm Rauch ... J Leung
Cancer Research | VOL. 78
Gm Rauch, et. al.Gm Rauch ... J Leung
14 Feb 2018
Predictive Markers of Treatment Response to Neoadjuvant Systemic Therapy with Dual HER2-Blockade.
Soong June Bae ... Min Ji Lee
Cancers | VOL. 16
Soong June Bae, et. al.Soong June Bae ... Min Ji Lee
19 Feb 2024
Tumor-Infiltrating Lymphocyte Level Consistently Correlates with Lower Stiffness Measured by Shear-Wave Elastography: Subtype-Specific Analysis of Its Implication in Breast Cancer.
Na Lae Eun ... Yoon Jin Cha
Cancers | VOL. 16
Na Lae Eun, et. al.Na Lae Eun ... Yoon Jin Cha
22 Mar 2024
Predicting the Level of Tumor-Infiltrating Lymphocytes in Patients With Breast Cancer: Usefulness of Mammographic Radiomics Features.
Hongwei Yu ... Xiuxiu Liu
Frontiers in Oncology | VOL. 11
Hongwei Yu, et. al.Hongwei Yu ... Xiuxiu Liu
11 Mar 2021
View more papers

More From: Pathology and Oncology Research

Paper Title
Journal
Date
Author
Evaluating the correlation between pretreatment 18F-FDG PET/CT metabolic parameters and tumor-infiltrating lymphocyte levels in nonluminal breast cancer and impact on survival
Muge Tamam ... Gunduzalp Bugrahan Babacan
Pathology and Oncology Research | VOL. -
Muge Tamam, et. al.Muge Tamam ... Gunduzalp Bugrahan Babacan
08 Jan 2025
NTRK amplification occurs frequently in pan-TRK immunopositive dedifferentiated liposarcomas
Zoltán Lippai ... Zoltán Sápi
Pathology and Oncology Research | VOL. 30
Zoltán Lippai, et. al.Zoltán Lippai ... Zoltán Sápi
07 Jan 2025
Anti-ceramide antibody and sphingosine-1-phosphate as potential biomarkers of unresectable non-small cell lung cancer
Lilla Bűdi ... Péter Horváth
Pathology and Oncology Research | VOL. 30
Lilla Bűdi, et. al.Lilla Bűdi ... Péter Horváth
06 Jan 2025
Examination of non-conventional dysplasias adjacent to colorectal adenocarcinoma in patients with IBD
Szintia Almási ... Anita Sejben
Pathology and Oncology Research | VOL. 30
Szintia Almási, et. al.Szintia Almási ... Anita Sejben
03 Jan 2025
View more papers

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.